Trastuzumab deruxtecan is an US FDA approved medication that is recommended for multiple cancer treatments. It is used in the management of breast cancer, gastric and gastroesophageal cancers. Its mechanism of action is unique, it works by blocking HER2/neu signaling and ultimately causing the death of cancer cells. The trade name of Trastuzumab deruxtecan is Enhertu, it is administered through intravenous infusion. It is commercially available as Enhertu 100 mg vials in the international markets. This advanced medication is developed by Daiichi Sankyo and promoted by AstraZeneca worldwide. Trastuzumab deruxtecan Price in India is determined based on the international trends and prices.
Enhurtu 100 mg – US FDA and EMA Approval of Trastuzumab deruxtecan
Daiichi Sankyo has secured Trastuzumab deruxtecan FDA approval in December 2019, as accelerated approval with fast track designation. EMA granted its approval in December 2020. It was subsequently approved Japan and Australia. The clinical research outcomes are in favor of this advanced option that can offer better advantages over the currently available options in many parts of the world.
Oncologists recommend Enhertu 100 mg vails in accordance with the standard protocols and dosage recommendations. It is selectively prescribed in adult patients with unresectable or metastatic HER2 positive breast cancer. Patients who received a prior anti-HER2-based treatment are ideal candidates for this.
Enhertu cost would matter once the choice of treatment is clearly explained to the patients. Dosage recommendations would matter the most in order to help patients to evaluate multiple factors regarding Trastuzumab deruxtecan treatment.
Trastuzumab deruxtecan Cost in India – Access and sourcing related information
Enhertu cost in India is calculated from the perspective of specific patient requirements. The price of Trastuzumab deruxtecan in India is mostly impacted because of the lack of easy access to this product. It is usual for patients to consider various options that are also cost effective. Many lifesaving products are often searched online. There has to be more than online information to help patients to gain confidence about the suppliers. Reliability of any source or supplier can be assessed based on the feedback from the hospital or treating physicians. Hospital references are usually trusted for their experience in the field. Many lifesaving medicines are recommended by the experts with a clear objective of achieving prolonged survival benefits. In some cases, the suppliers who offer low cost services many not guarantee quality product that indirectly impact the patient’s health. It doesn’t mean that the expensive products are good and reliable by default. A careful assessment should be done to determine all the aspects of delivering medicines.
Reliable procurement of Trodelvy (Sacituzumab govitecan)
Specialty medicines require temperature specific storage and shipment provisions. The quality of the product directly depends on the storage and shipment quality. This matters the most for Indian patients who require advanced and specialized medications that are unavailable right now in the country. Patients require to procure import permit from CDSCO to initiate the import process from any international location. It is not a very complex process and patients can take the help of authorized agencies for fast tract the same. Service providers that are experienced in delivering specialty medicines like Sourcing Enhertu (Trastuzumab deruxtecan) in India may be counted for reliable procurement.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com